PET: a revolution in medical imaging.
FDG-PET has had remarkable influence on the assessment of physiologic and pathologic states. The authors predict that FDG-PET imaging could soon become the most common procedure used by nuclear medicine laboratories and could remain so for an extended period of time. The power of molecular imaging lies in the vast potential for using biochemical and pharmacologic probes to extend applications arising from an understanding of cell biology to a large number of well-characterized pathologic states. Molecular imaging based upon tracer kinetics with positron-emitting radiopharmaceuticals could become the main source of information for the management of cancer patients. In that case, nuclear medicine procedures might become the most common imaging studies performed in the practice of medicine. This speculation is not farfetched when one realizes the enormous change that a single biologically important compound, FDG, has brought to the medical arena. The major challenge today is to attract the highly qualified individuals and to secure the resources needed to harness the opportunities in the specialty of molecular imaging.
Alavi
Abass
A
Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. abass.alavi@uphs.upenn.edu
Lakhani
Paras
P
Mavi
Ayse
A
Kung
Justin W
JW
Zhuang
Hongming
H
D019788:Fluorodeoxyglucose F18; D006801:Humans; D008967:Molecular Biology; D009369:Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy; D009422:Nervous System Diseases / Q000000981:diagnostic imaging / Q000628:therapy; D010347:Patient Care Planning; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18